413 related articles for article (PubMed ID: 36983038)
1. Chalcones and Gastrointestinal Cancers: Experimental Evidence.
Michalkova R; Kello M; Cizmarikova M; Bardelcikova A; Mirossay L; Mojzis J
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983038
[TBL] [Abstract][Full Text] [Related]
2. Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer.
WalyEldeen AA; Sabet S; El-Shorbagy HM; Abdelhamid IA; Ibrahim SA
Chem Biol Interact; 2023 Jan; 369():110297. PubMed ID: 36496109
[TBL] [Abstract][Full Text] [Related]
3. Chalcone Derivatives and their Activities against Drug-resistant Cancers: An Overview.
Xiao J; Gao M; Diao Q; Gao F
Curr Top Med Chem; 2021; 21(5):348-362. PubMed ID: 33092509
[TBL] [Abstract][Full Text] [Related]
4. Natural Chalcones and Their Derivatives Target the Tumor Microenvironment in Colon Cancer.
Malla RR; Siragam S; Dadi V; Seetini B
Crit Rev Immunol; 2022; 42(6):27-39. PubMed ID: 37082949
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Potential of Natural Chalcones: In Vitro and In Vivo Evidence.
Michalkova R; Mirossay L; Kello M; Mojzisova G; Baloghova J; Podracka A; Mojzis J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373500
[TBL] [Abstract][Full Text] [Related]
6. Chalcones against the hallmarks of cancer: a mini-review.
de Souza PS; Bibá GCC; Melo EDDN; Muzitano MF
Nat Prod Res; 2022 Sep; 36(18):4809-4826. PubMed ID: 34865580
[TBL] [Abstract][Full Text] [Related]
7. Structure optimization of an F-indole-chalcone (FC116) on 4-methoxyphenyl group and therapeutic potential against colorectal cancers with low cytotoxicity.
Du B; Liu X; Luan X; Zhang W; Zhuang C
Bioorg Chem; 2023 Jun; 135():106531. PubMed ID: 37043882
[TBL] [Abstract][Full Text] [Related]
8. Chalcone Derivatives: Role in Anticancer Therapy.
Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
[TBL] [Abstract][Full Text] [Related]
9. Advances in chalcones with anticancer activities.
Karthikeyan C; Moorthy NS; Ramasamy S; Vanam U; Manivannan E; Karunagaran D; Trivedi P
Recent Pat Anticancer Drug Discov; 2015; 10(1):97-115. PubMed ID: 25138130
[TBL] [Abstract][Full Text] [Related]
10. Chalcones derivatives acting as cell cycle blockers: potential anti cancer drugs?
Boumendjel A; Ronot X; Boutonnat J
Curr Drug Targets; 2009 Apr; 10(4):363-71. PubMed ID: 19355861
[TBL] [Abstract][Full Text] [Related]
11. Chalcones: Synthetic Chemistry Follows Where Nature Leads.
Jasim HA; Nahar L; Jasim MA; Moore SA; Ritchie KJ; Sarker SD
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439870
[TBL] [Abstract][Full Text] [Related]
12. Targeting Ovarian Cancer with Chalcone Derivatives: Cytotoxicity and Apoptosis Induction in HGSOC Cells.
Merve Aydin E; Canıtez İS; Colombo E; Princiotto S; Passarella D; Dallavalle S; Christodoulou MS; Durmaz Şahin I
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067507
[TBL] [Abstract][Full Text] [Related]
13. Anti-cancer chalcones: Structural and molecular target perspectives.
Mahapatra DK; Bharti SK; Asati V
Eur J Med Chem; 2015 Jun; 98():69-114. PubMed ID: 26005917
[TBL] [Abstract][Full Text] [Related]
14. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
15. Chalcone Derivatives 4'-Amino-1-Naphthyl-Chalcone (D14) and 4'-Amino-4-Methyl-1-Naphthyl-Chalcone (D15) Suppress Migration and Invasion of Osteosarcoma Cells Mediated by p53 Regulating EMT-Related Genes.
Seba V; Silva G; Santos MBD; Baek SJ; França SC; Fachin AL; Regasini LO; Marins M
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235848
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities.
Srinivasan B; Johnson TE; Lad R; Xing C
J Med Chem; 2009 Nov; 52(22):7228-35. PubMed ID: 19883086
[TBL] [Abstract][Full Text] [Related]
17. Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications.
Mahapatra DK; Bharti SK; Asati V; Singh SK
Eur J Med Chem; 2019 Jul; 174():142-158. PubMed ID: 31035237
[TBL] [Abstract][Full Text] [Related]
18. New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer.
Rodrigues J; Abramjuk C; Vásquez L; Gamboa N; Domínguez J; Nitzsche B; Höpfner M; Georgieva R; Bäumler H; Stephan C; Jung K; Lein M; Rabien A
Pharm Res; 2011 Apr; 28(4):907-19. PubMed ID: 21184149
[TBL] [Abstract][Full Text] [Related]
19. Anticancer Activity of Natural and Synthetic Chalcones.
Constantinescu T; Lungu CN
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768736
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor.
Cai CY; Zhang W; Wang JQ; Lei ZN; Zhang YK; Wang YJ; Gupta P; Tan CP; Wang B; Chen ZS
Biochem Pharmacol; 2020 May; 175():113848. PubMed ID: 32044354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
